Detalles de la búsqueda
1.
A phase II trial of ixabepilone and cyclophosphamide as neoadjuvant therapy for patients with HER2-negative breast cancer: correlation of pathologic complete response with the 21-gene recurrence score.
Breast Cancer Res Treat
; 154(2): 299-308, 2015 Nov.
Artículo
en Inglés
| MEDLINE | ID: mdl-26507191
2.
Phase I/II trial of neoadjuvant sunitinib administered with weekly paclitaxel/carboplatin in patients with locally advanced triple-negative breast cancer.
Breast Cancer Res Treat
; 152(3): 557-67, 2015 Aug.
Artículo
en Inglés
| MEDLINE | ID: mdl-26155975
3.
Paclitaxel, bevacizumab, and everolimus/placebo as first-line treatment for patients with metastatic HER2-negative breast cancer: a randomized placebo-controlled phase II trial of the Sarah Cannon Research Institute.
Breast Cancer Res Treat
; 154(1): 89-97, 2015 Nov.
Artículo
en Inglés
| MEDLINE | ID: mdl-26456573
4.
Patient perspectives on breast cancer treatment plan and summary documents in community oncology care: a pilot program.
Cancer
; 119(1): 164-72, 2013 Jan 01.
Artículo
en Inglés
| MEDLINE | ID: mdl-23197335
5.
Phase 1 results from a study of romidepsin in combination with gemcitabine in patients with advanced solid tumors.
Cancer Invest
; 30(6): 481-6, 2012 Jul.
Artículo
en Inglés
| MEDLINE | ID: mdl-22536933
6.
A phase II feasibility trial of dose-dense docetaxel followed by doxorubicin/cyclophosphamide as adjuvant or neoadjuvant treatment for women with node-positive or high-risk node-negative breast cancer.
Clin Breast Cancer
; 8(3): 242-8, 2008 Jun.
Artículo
en Inglés
| MEDLINE | ID: mdl-18650154
7.
Antiemetic guideline consistency and incidence of chemotherapy-induced nausea and vomiting in US community oncology practice: INSPIRE Study.
J Oncol Pract
; 10(1): 68-74, 2014 Jan.
Artículo
en Inglés
| MEDLINE | ID: mdl-24065402
8.
A phase II trial of neoadjuvant gemcitabine, epirubicin, and docetaxel as primary treatment of patients with locally advanced or inflammatory breast cancer.
Clin Breast Cancer
; 10(3): 217-23, 2010 Jun.
Artículo
en Inglés
| MEDLINE | ID: mdl-20497920
9.
Phase I dose escalation and pharmacokinetic study of lapatinib in combination with trastuzumab in patients with advanced ErbB2-positive breast cancer.
J Clin Oncol
; 26(20): 3317-23, 2008 Jul 10.
Artículo
en Inglés
| MEDLINE | ID: mdl-18490651
Resultados
1 -
9
de 9
1
Próxima >
>>